CRSP icon

CRISPR Therapeutics

39 hedge funds and large institutions have $155M invested in CRISPR Therapeutics in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 5 closing their positions.

Holders
39
Holders Change
+4
Holders Change %
+11.43%
% of All Funds
0.97%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
9
Increased
6
Reduced
8
Closed
5
Calls
$1K
Puts
$322K
Net Calls
-$321K
Net Calls Change
-$321K
Name Holding Trade Value Shares
Change
Shares
Change %
AG
26
Advisor Group
Arizona
$14K +$9.33K +600 +200%
FDCDDQ
27
Federation des caisses Desjardins du Quebec
Quebec, Canada
$12.8K +$2.44K +152 +23%
LWCFA
28
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$10K
Deutsche Bank
29
Deutsche Bank
Germany
$8K -$102K -6,400 -93%
MFW
30
Mosaic Family Wealth
Missouri
$8K
CFA
31
Carroll Financial Associates
North Carolina
$7K
IP
32
Intellectus Partners
California
$7K
KF
33
Krilogy Financial
Missouri
$5K +$5K +300 New
CG
34
Cutler Group
California
$5K +$5K +337 New
ASN
35
Advisory Services Network
Georgia
$2K
LTFS
36
Ladenburg Thalmann Financial Services
Florida
$2K
WIM
37
Westside Investment Management
California
$1.6K
CCM
38
Cribstone Capital Management
Maine
$1K
IWM
39
IHT Wealth Management
Illinois
$20 +80 +1%
Wellington Management Group
40
Wellington Management Group
Massachusetts
-$16.3M -747,450 Closed
DSI
41
Daiwa SB Investments
Japan
-$61K -2,800 Closed
TDC
42
Thompson Davis & Co
Virginia
-$54K -2,500 Closed
Citigroup
43
Citigroup
New York
-$2K -100 Closed
US Bancorp
44
US Bancorp
Minnesota
-$1K -39 Closed
MIM
45
Monashee Investment Management
Massachusetts
-$473K